Inventor · disambiguated record
Pierre-Olivier Vidalain
Also filed as: VIDALAIN PIERRE- OLIVIER
1 granted patent·5 pending applications·0 citations·filing 2009–2021
5Inventor score
Files withINST NAT SANTE RECH MED2CENTRE NAT RECH SCIENT1PASTEUR INSTITUT1UNIV VANDERBILT1VIDALAIN PIERRE-OLIVIER1
Top patents by PatentIndex Score
6 records- 0150US2024000885A1Compositions and methods for targeting the interaction of host myo5b+d and coronavirus m proteinsUNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 0246US2023181539A1Methods for the treatment of coronavirus infectionsINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0346US2023146096A1Use of vidofludimus for the treatment of coronavirus infectionsINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0443US2011159480A1Cell-based screening assay to identify molecules that stimulate ifn-alpha/beta target genesPASTEUR INSTITUT·Filed 2009·Application pending·0 cites
- 0528US2020393446A1Bioluminescent screening test for detecting cell cytolysisCENTRE NAT RECH SCIENT·Filed 2018·Application pending·0 cites
- 0627US9315482B2Derivatives useful as antiviral agentsVIDALAIN PIERRE-OLIVIER·Filed 2011·Granted Apr 19, 2016·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Pierre-Olivier Vidalain files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →